JW Therapeutics is a biotech company focusing on clinical cell therapy technology. The Company is aimed to develop, transform and promote breakthrough cell-based immunotherapies to fight against cancer.
Type | Private | |
Founded | 2016 | |
HQ | CN | Map |
Website | jwtherapeutics.com |
Employees (est.) (Aug 2022) | 96 | |
Cybersecurity rating | A | More |
Founding Date | 2016 |
JW Therapeutics total Funding | $90 m |
JW Therapeutics latest funding size | $90 m |
Time since last funding | 4 years ago |
JW Therapeutics investors | Temasek Holdings, WuXi AppTec, Juno Therapeutics, YuanMing Capital, Oriza Seed Capital, Sequoia Capital China, AVICT Global Holdings, Yipu Capital |
Company Name | Date | Deal Size |
---|---|---|
Syracuse Biopharma | July 26, 2020 |
When was JW Therapeutics founded?
JW Therapeutics was founded in 2016.
Who are JW Therapeutics key executives?
JW Therapeutics's key executives are Harry Lam, Xin Fu and Shaun Paul Cordoba.
How many employees does JW Therapeutics have?
JW Therapeutics has 96 employees.
Who are JW Therapeutics competitors?
Competitors of JW Therapeutics include Neovii, Eutilex and Foghorn Therapeutics.
Where are JW Therapeutics offices?
JW Therapeutics has an office in Suzhou Shi.
How many offices does JW Therapeutics have?
JW Therapeutics has 4 offices.
Receive alerts for 300+ data fields across thousands of companies